PD‐1 inhibitor‐related pneumonitis in lymphoma patients treated with single‐agent pembrolizumab therapy

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of haematology 2018-03, Vol.180 (5), p.752-755
Hauptverfasser:	Nishino, Mizuki, Ramaiya, Nikhil H., Hatabu, Hiroto, Hodi, F. Stephen, Armand, Philippe F.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenal Cortex Hormones - therapeutic use Aged Antibodies, Monoclonal, Humanized - adverse effects Antineoplastic Agents, Immunological - adverse effects Female Hematology Humans immune‐related adverse event Immunotherapy Lymphoma Lymphoma - drug therapy Male Middle Aged Monoclonal antibodies PD‐1 inhibitor pembrolizumab Pneumonia - chemically induced Pneumonia - drug therapy Pneumonitis Targeted cancer therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!